Nec-1 pretreatment reduced necroptosis by inhibiting RIPK1- RIPK3-MLKL pathway in OA-induced ARDS and decreased aggregation of inflammatory cells and TNF-a level in BALF. This evidence concerns the gene RIPK3 and acute respiratory distress syndrome.